AKEBIA THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -381.1% | -381.1% | -53.3% |
| FY2022 | -1,801.6% | -239.7% | -26.5% |
| FY2023 | 169.8% | 387.5% | -21.5% |
| FY2024 | 141.1% | 661.6% | -31.5% |
| FY2025 | -16.4% | -6.6% | -1.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -381.1% | -381.1% | -53.3% |
| FY2022 | -1,801.6% | -239.7% | -26.5% |
| FY2023 | 169.8% | 387.5% | -21.5% |
| FY2024 | 141.1% | 661.6% | -31.5% |
| FY2025 | -16.4% | -6.6% | -1.4% |